Related Experiment Video
Updated: May 24, 2026
10:00
Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
Published on: December 11, 2020
Oxidative stress in patients with primary insomnia
Mustafa Gulec1, Halil Ozkol, Yavuz Selvi
1Department of Psychiatry, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|March 10, 2012
Summary
Primary insomnia is linked to increased oxidative stress, indicated by lower glutathione peroxidase activity and higher malondialdehyde levels. This suggests sleep plays a crucial role in managing oxidative stress and preventing neurodegeneration.
Area of Science:
- Neuroscience
- Biochemistry
- Sleep Medicine
Background:
- Oxidative stress, caused by free radicals, is implicated in neurodegenerative disorders.
- Insomnia is a widespread health issue affecting overall well-being.
Purpose of the Study:
- To investigate the relationship between primary insomnia and oxidative stress biomarkers.
- To assess specific markers including glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), myeloperoxidase (MPO), reduced glutathione (GSH), and malondialdehyde (MDA).
Main Methods:
- A comparative study involving 30 patients with primary insomnia and 30 healthy controls.
- Measurement of enzymatic activities (GSH-Px, SOD, MPO) and levels of specific molecules (GSH, MDA).
Main Results:
- Patients with primary insomnia exhibited significantly reduced glutathione peroxidase (GSH-Px) activity.
- Elevated levels of malondialdehyde (MDA), a marker of lipid peroxidation, were observed in the insomnia group.
Conclusions:
- The findings suggest a potential role for sleep in mitigating oxidative stress.
- Primary insomnia may be associated with an imbalance in oxidative stress markers.
Related Concept Videos
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:13Insufficient Sleep and Sleep Deprivation
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...